6,045 filings
6-K
GSK
GSK Plc
24 Jun 24
Ema Validates Jemperli Marketing Authorisation
6:10am
6-K
GSK
GSK Plc
24 Jun 24
Omjjara Approved In Japan for Myelofibrosis
6:05am
6-K
GSK
GSK Plc
21 Jun 24
Director/pdmr Shareholding
11:08am
11-K
GSK
GSK Plc
18 Jun 24
Annual report of employee stock purchases
4:20pm
11-K
GSK
GSK Plc
18 Jun 24
Annual report of employee stock purchases
4:18pm
6-K
q5sty0h
12 Jun 24
Director/pdmr Shareholding
11:19am
6-K
nizsqz1
11 Jun 24
Statement: Zantac (Ranitidine) Litigation
6:11am
6-K
ka2a1vcy
10 Jun 24
Statement: Zantac (Ranitidine) Litigation
1:44pm
6-K
xlo g772l
10 Jun 24
Fda Approves Arexvy for Adults 50-59 at Risk
6:28am
25-NSE
ad18ldsfo3mhpm
3 Jun 24
Exchange delisting
1:37pm
6-K
2sunns2lryain w1wm9
3 Jun 24
Total Voting Rights
10:39am
6-K
61xjq g39a1daj5
3 Jun 24
Unprecedented Results In Jemperli Trial Continue
8:56am
6-K
cpwqf856
3 Jun 24
Asco Positive Blenrep DREAMM-8 Trial Results
6:11am
6-K
tfcha6h7hb7d8gg4fc7
3 Jun 24
Statement: Zantac (Ranitidine) Litigation
6:05am
SD
a7iij0 u9w7
31 May 24
Conflict minerals disclosure
4:21pm
6-K
zqf8o ksd7p
24 May 24
Statement: Zantac (Ranitidine) Litigation
6:24am
6-K
3pocob
21 May 24
Positive Phase III Asthma Results for Depemokimab
6:17am
6-K
pt85a fr0jpo39hwhl
20 May 24
Director/pdmr Shareholding
10:49am
6-K
6y5zz7fsnjf82fgs0v
17 May 24
Current Report
11:16am
6-K
1fkrds7rqyq89la
17 May 24
GSK Completes Sale of Shares In Haleon PLC
6:00am